Skip to search formSkip to main contentSkip to account menu

SCH 23390

Known as: SCH-23390, SCH23390 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Wistar male rats were implanted with bipolar electrodes in the lateral hypothalamus to study self-stimulation reaction in the… 
2008
2008
Abstract : The objective of this proposal is to study genetic and neuroendocrine biomarkers of risk in a carefully assessed… 
2004
2004
Biochemical, electrophysiological, and behavioral experiments suggest that the dopamine D-1 and D-2 receptor subtypes… 
2002
2002
The neuroanatomical and functional relationships between dopamine (DA) and neurotensin (NT) and DA and neuropeptide Y (NPY… 
2001
2001
: The present study was designed to compare the putative differential behavioral consequences of treatment with SCH23390 (a… 
1996
1996
Effects of a novel TRH analog, montirelin hydrate (NS-3), on the coma caused by head concussion and narcosis induced by… 
1987
1987
The renal vascular effects of dopaminomimetics and dopaminolytics were studied in the isolated perfused rat kidney after… 
Review
1986
Review
1986
The recent identification of the first selective D1 dopamine (DA) receptor antagonist, the 1-phenyl-1H-3-benzazepine derivative… 
1986
1986
This study was designed to investigate dopaminergic mechanisms in human vasculature using the selective vascular dopamine… 
Highly Cited
1984
Highly Cited
1984
Intravenous (i.v.) infusions of SCH 23390 (R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7- ol) produced…